Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Minneapolis, Minnesota 55455


Purpose:

Study Design: This is a randomized, single center study to evaluate immune responses to the seasonal influenza vaccine in allogeneic hematopoietic stem cell transplant (HSCT) recipients who receive one vaccine or two vaccine doses one month apart. In addition, a cohort of healthy adult volunteers will be recruited as controls to confirm immune response to a single influenza vaccine.


Criteria:

Inclusion Criteria: - Patient Population - HSCT recipients who are greater than 60 days post transplant. - Age 6 months and older who are greater than 60 days post post allogeneic hematopoietic cell transplant - Show neutrophil recovery, platelet count > 50,000/mm3 (may be transfused), no known disease relapse - No history of previous allergic reaction to influenza vaccine, known egg allergy or Guillan-Barre Syndrome - No flu vaccine in previous 4 months, no Campath in previous 6 months, no intravenous immune globulin (IVIG) in previous 3 months - Controls: - Age 18 to 50 years - No history of previous allergic reaction to influenza vaccine, known egg allergy or Guillan-Barre Syndrome - No flu vaccine in previous 4 months


NCT ID:

NCT01215981


Primary Contact:

Principal Investigator
Michael Verneris, M.D.
Masonic Cancer Center, University of Minnesota


Backup Contact:

N/A


Location Contact:

Minneapolis, Minnesota 55455
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.